AFCG Q2: Net Investment Income Rises, But Justice Cannabis Default Looms
AFCG sits 37% above its 52-week low of $2.06.
Summary
AFCG reported Q2 net investment income of $3.48M, but its largest loan to Justice Cannabis matured unpaid, leaving $78.8M in litigation. Nonaccruals remain high at 22.7% of fair value.
Updates
· GlobeNewswire — NAV per share rose to $8.25 from $7.90, including $0.17 accretion from repurchasing 839,406 shares at $3.29, a 60% discount to NAV. Portfolio grew to $289.8M across 17 companies with 13.2% weighted average yield.
Key Events · Earnings and Guidance · AFCG
-
Justice Cannabis Loan Defaults at Maturity
The $78.8M credit facility to Justice Cannabis Company matured May 1, 2026 without repayment. AFCG is pursuing litigation and has noticed collateral dispositions for September 24 and October 6, 2026.
-
Nonaccrual Investments Remain Elevated
Three portfolio companies are on nonaccrual status, representing 22.7% of total debt investments at fair value ($65.9M fair value vs $126.5M amortized cost).
-
Q2 Net Investment Income Positive
Net investment income was $3.48M for Q2 2026, up from a net loss of $13.16M in Q2 2025, driven by higher interest income and lower credit loss provisions.
-
Leverage Increased Temporarily
Revolving credit facility was temporarily increased to $110M and fully drawn at quarter end. On July 1, 2026, the company repaid $84.4M on the revolver and $20M on the TCGSL facility.
Analysis · AFCG · Unknown
Advanced Flower Capital swung to positive net investment income of $3.48M in Q2 2026, but the quarter is overshadowed by the maturity of its largest loan — Justice Cannabis Company — without repayment. The $78.8M exposure, now in active litigation, represents a substantial portion of the company's $187M net assets. Nonaccrual investments remain elevated at 22.7% of fair value, and the company is pursuing collateral dispositions scheduled for September and October 2026. The company also drew down its full $110M revolving credit facility, though it repaid $84.4M on July 1, 2026. The new $5M buyback program and insider accumulation provide some support, but the credit risk is the dominant story.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 37.5% of the 993 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.86%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AFCG was trading at $2.82 on NASDAQ in the Unknown sector, with a market capitalization of approximately $64.3M. The 52-week trading range was $2.06 to $5.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.